Gara Jalqabaatti › Baayyee Ulfaataa › Nevada › Las Vegas
Qorannoo klinikaalii Baayyee Ulfaataa Las Vegas, NV keessatti
Qorannoo 23 Baayyee Ulfaataa f Las Vegas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Vector Clinical Trials, Las Vegas
- Palm Research Center Inc, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Palm Research Center Inc, Las Vegas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Excel Clinical Research, Las Vegas
- Vector Clinical Trials, Las Vegas
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Vector Clinical Trials /ID# 282265, Las Vegas
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- M3 Wake Research - Las Vegas Cimarron, Las Vegas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Palm Research Center Inc., Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Las Vegas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Las Vegas Medical Research, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Palm Research Center Tenaya, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AMR Clinical, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Las Vegas
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
- ACCOMPLISH-2 Research Site, Las Vegas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
- Jubilee Clinical Research, Inc., Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Vector Clinical Trials, Las Vegas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Las Vegas Medical Research, Las Vegas
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Las Vegas
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Las Vegas
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University of Nevada, Las Vegas, Las Vegas
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Excel Clinical Research, Las Vegas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Las Vegas
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Las Vegas
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Namoota walitti qabaa jiraSadarkaa 1
- Corxel Investigational site, Las Vegas
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
- Baltimore, MDQorannoo 18
Qorannoo biroo Las Vegas keessatti
- ObesityQorannoo 27
- Sukkaraa Gosa 2Qorannoo 18
- Kansara Qara'a Non-Small CellQorannoo 13
- Dhibee Gaddii GuddaaQorannoo 13
- Saree OljooQorannoo 10
- Dhukkubaa AlzheimerQorannoo 8
- Leukemia Myeloidii HamaaQorannoo 8
- Kansarii ProstateQorannoo 8
- Saree (Gosoota Hunda)Qorannoo 8
- SchizophreniaQorannoo 7
- AtherosclerosisQorannoo 7
- Dhukkubaa Harkaa SteatoticQorannoo 7
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.